The Kansas City Chiefs announced plans to move away from Arrowhead Stadium, where the team has played since its inception in 1972 Getty(2) Travis Kelce emotionally reacted to the relocation of the ...

Dr. Anzalone explained, "We anticipate being funded through multiple potential independent and partner launches. These meaningfully increase revenue opportunities... and push us toward becoming cash ...

Saturday's $250,000 Sam F. Davis S. at Tampa Bay Downs isn't the richest or most prestigious Road to the Kentucky Derby qualifier taking place this week, but it's drawn some of the most promising ...

IT MAKES IT SO SPECIAL FOR STEELER NATION. WHEN THE SONG RENEGADE PLAYS PITTSBURGH STEELERS FANS AND PLAYERS KNOW THERE’S GOING TO BE A CRITICAL MOMENT IN THE GAME. I TALKED WITH A BAND MEMBER OF STYX ...

A new analysis of ancient arrowheads from South Africa pushes back prehistoric humans’ earliest use of poisoned weapons by more than 50,000 years. “This is the earliest direct evidence of the use of ...

Arrowhead has raised $3 Mn (INR 27 Cr) funding in its seed round led by early-stage focussed VC firm Stellaris Venture Partners The round also saw participation from CRED’s founder Kunal Shah, M2P ...

Archaeologists recently uncovered the remains of a long-lost medieval village, thanks to pre-construction excavations for an offshore wind farm project. On Dec. 9, Wessex Archaeology announced its ...

Arrowhead Pharmaceuticals (ARWR) added ~12% in the premarket on Tuesday after the company said that its experimental obesity therapy ARO-INHBE doubled weight loss in an early-stage trial in ...

, Inc. (NASDAQ: ARWR) on Tuesday shared interim results from two Phase 1/2a trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics for obesity.

Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting preliminary evidence that the molecules help people shed fat to send its stock ...

- ARO-INHBE in combination with tirzepatide achieved -9.4% weight loss at week 16 in obese patients with type 2 diabetes mellitus, demonstrating an approximately two-fold improvement versus -4.8% on ...